CVS Health Corporation [CVS] moved down -0.80: Why It’s Important

CVS Health Corporation [NYSE: CVS] slipped around -0.82 points on Tuesday, while shares priced at $101.19 at the close of the session, down -0.80%. The company report on December 1, 2022 that CVS Health Opens MinuteClinic Locations in Delaware.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Northern DE residents now have access to high-quality, affordable and convenient care at MinuteClinic.

CVS Health® (NYSE: CVS) today announced it has opened its first MinuteClinic locations in northern Delaware. MinuteClinic, the medical clinics inside select CVS Pharmacy stores, provides high-quality, affordable and convenient care for a wide variety of acute and chronic conditions for patients ages 18 months and older.

CVS Health Corporation stock is now -1.91% down from its year-to-date (YTD) trading value. CVS Stock saw the intraday high of $102.72 and lowest of $100.54 per share. The company’s 52-week high price is 111.25, which means current price is +17.28% above from all time high which was touched on 02/08/22.

Compared to the average trading volume of 5.95M shares, CVS reached a trading volume of 4058081 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about CVS Health Corporation [CVS]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $117.81 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Morgan Stanley have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 23, 2022. While these analysts kept the previous recommendation, Loop Capital raised their target price to Buy. The new note on the price target was released on June 17, 2022, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another drop from $122 to $112, while Bernstein kept a Mkt Perform rating on CVS stock.

The Average True Range (ATR) for CVS Health Corporation is set at 2.03, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.42. The Price to Book ratio for the last quarter was 1.88, with the Price to Cash per share for the same quarter was set at 15.35. Price to Free Cash Flow for CVS in the course of the last twelve months was 7.91 with Quick ratio for the last quarter at 0.70.

How has CVS stock performed recently?

CVS Health Corporation [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.31. With this latest performance, CVS shares gained by 1.64% in over the last four-week period, additionally plugging by 5.49% over the last 6 months – not to mention a rise of 9.22% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 58.08, with the RSI for the last a single of trading hit 58.07, and the three-weeks RSI is set at 56.70 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 96.36, while it was recorded at 101.86 for the last single week of trading, and 98.76 for the last 200 days.

CVS Health Corporation [CVS]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.12 and a Gross Margin at +17.77. CVS Health Corporation’s Net Margin is presently recorded at +2.71.

Return on Equity for this stock inclined to 10.95, with Return on Assets sitting at 3.30.

CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.90.

Earnings analysis for CVS Health Corporation [CVS]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 5.47%.

Insider trade positions for CVS Health Corporation [CVS]

There are presently around $105,066 million, or 80.60% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 115,934,841, which is approximately 1.512% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 93,850,627 shares of the stock with an approximate value of $9.5 billion in CVS stocks shares; and CAPITAL WORLD INVESTORS, currently with $6.16 billion in CVS stock with ownership of nearly 3.502% of the company’s market capitalization.

Positions in CVS Health Corporation stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 1,164 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 35,727,822 shares. Additionally, 1,034 investors decreased positions by around 29,626,245 shares, while 241 investors held positions by with 972,946,805 shares. The mentioned changes placed institutional holdings at 1,038,300,872 shares, according to the latest SEC report filing. CVS stock had 140 new institutional investments in for a total of 3,204,351 shares, while 98 institutional investors sold positions of 2,525,364 shares during the same period.


Please enter your comment!
Please enter your name here